D
RenovoRx, Inc. RNXT
$0.972 -$0.018-1.82% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -12.93% -20.09% -16.69% -14.19% 1.42%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -3.36% -14.20% -6.36% 3.97% 14.53%
Operating Income 3.74% 14.20% 6.36% -3.97% -14.53%
Income Before Tax 13.86% -0.02% 17.85% 20.63% -3.47%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 13.86% -0.02% 17.85% 20.63% -3.47%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 13.86% -0.02% 17.85% 20.63% -3.47%
EBIT 3.74% 14.20% 6.36% -3.97% -14.53%
EBITDA -- 84.93% 56.61% 20.30% -14.54%
EPS Basic 61.93% 39.59% 42.28% 35.13% 7.49%
Normalized Basic EPS 61.93% 39.59% 42.26% 35.12% 7.49%
EPS Diluted 61.93% 39.59% 42.28% 35.13% 7.49%
Normalized Diluted EPS 61.93% 39.59% 42.26% 35.12% 7.49%
Average Basic Shares Outstanding 116.46% 88.82% 59.33% 29.45% 13.62%
Average Diluted Shares Outstanding 116.46% 88.82% 59.33% 29.45% 13.62%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --